{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T18:43:33Z","timestamp":1777747413747,"version":"3.51.4"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Recent reports have reported an increase in the incidence of acute mastoiditis because of <jats:italic toggle=\"yes\">Fusobacterium necrophorum.<\/jats:italic> However, the crude incidence and the specific clinical and laboratory characteristics of <jats:italic toggle=\"yes\">F. necrophorum<\/jats:italic> mastoiditis in children have not been described. Our aim was to describe these features to identify high-risk patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The electronic medical records of all children with acute mastoiditis at a tertiary medical center between July 2011 and December 2015 were analyzed. Using a stepwise logistic regression to identify independent risk factors for <jats:italic toggle=\"yes\">F. necrophorum<\/jats:italic>, we formulated a predictive model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">F. necrophorum<\/jats:italic> was identified in 13% (19\/149) of mastoiditis cases with an identifiable agent. Its incidence increased 7-fold from 2.8% in 2012 to 20.4% in 2015 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.02). <jats:italic toggle=\"yes\">F. necrophorum<\/jats:italic> infection had unique clinical, laboratory and prognostic features. The vast majority had complications and underwent surgical intervention. The predictive model used 4 parameters to define high-risk patients for <jats:italic toggle=\"yes\">F. necrophorum<\/jats:italic> infection at admission: females, winter\/spring season, prior antibiotic treatment and a C-reactive protein value &gt;20\u2009mg\/dL (area under receiver operating characteristic curve 0.929).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Clinicians should be aware of the increasing incidence of <jats:italic toggle=\"yes\">F. necrophorum<\/jats:italic> mastoiditis and consider anaerobic cultures and specific anaerobic coverage in high-risk patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002021","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T03:19:43Z","timestamp":1522293583000},"page":"12-15","source":"Crossref","is-referenced-by-count":29,"title":["Fusobacterium necrophorum as an Emerging Pathogen of Acute Mastoiditis"],"prefix":"10.1097","volume":"38","author":[{"given":"Miri","family":"Gelbart","sequence":"first","affiliation":[{"name":"Departments of Pediatrics A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efraim","family":"Bilavsky","sequence":"additional","affiliation":[{"name":"Pediatrics B"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Chodick","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Department of Epidemiology & Preventive Medicine, Tel Aviv, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Raveh","sequence":"additional","affiliation":[{"name":"Otolaryngology Unit"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzhak","family":"Levy","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Schneider Children\u2019s Medical Center of Israel, Petach Tikva, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liat","family":"Ashkenazi-Hoffnung","sequence":"additional","affiliation":[{"name":"Pediatrics C"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230928","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/0009922809344349","article-title":"Clinical strategies for the management of acute mastoiditis in the pediatric population.","volume":"49","author":"Lin","year":"2010","journal-title":"Clin Pediatr (Phila)"},{"key":"R2-20230928","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.ijporl.2009.05.019","article-title":"Clinical, laboratory, and microbiological differences between children with simple or complicated mastoiditis.","volume":"73","author":"Bilavsky","year":"2009","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R3-20230928","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11908-015-0479-4","article-title":"Challenges in the management of acute mastoiditis in children.","volume":"17","author":"Kordeluk","year":"2015","journal-title":"Curr Infect Dis Rep"},{"key":"R4-20230928","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/01.inf.0000091292.24683.fc","article-title":"Acute mastoiditis in Southern Israel: a twelve year retrospective study (1990 through 2001).","volume":"22","author":"Katz","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R5-20230928","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ijporl.2008.01.013","article-title":"Conservative management of acute mastoiditis in children.","volume":"72","author":"Geva","year":"2008","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R6-20230928","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.ijporl.2012.07.002","article-title":"Acute mastoiditis in children aged 0\u201316 years\u2014a national study of 678 cases in Sweden comparing different age groups.","volume":"76","author":"Groth","year":"2012","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R7-20230928","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijporl.2014.07.003","article-title":"Acute mastoiditis in children under 15 years of age in Southern Israel following the introduction of pneumococcal conjugate vaccines: a 4-year retrospective study (2009\u20132012).","volume":"78","author":"Kordeluk","year":"2014","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R8-20230928","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00006454-200104000-00003","article-title":"Acute mastoiditis in children: a seventeen-year experience in Dallas, Texas.","volume":"20","author":"Ghaffar","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R9-20230928","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/MAO.0b013e31817f736b","article-title":"A systematic review of diagnostic criteria for acute mastoiditis in children.","volume":"29","author":"van den Aardweg","year":"2008","journal-title":"Otol Neurotol"},{"key":"R10-20230928","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00405-011-1667-y","article-title":"Acute mastoiditis in children: 10 years experience in a French tertiary university referral center.","volume":"269","author":"Gorphe","year":"2012","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R11-20230928","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijporl.2012.10.003","article-title":"Fusobacterium necrophorum mastoiditis in children\u2014emerging pathogen in an old disease.","volume":"77","author":"Yarden-Bilavsky","year":"2013","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R12-20230928","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11908-013-0340-6","article-title":"Fusobacterial infections in children.","volume":"15","author":"Brook","year":"2013","journal-title":"Curr Infect Dis Rep"},{"key":"R13-20230928","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/CMR.00011-07","article-title":"Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre\u2019s syndrome.","volume":"20","author":"Riordan","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"R14-20230928","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s15010-015-0782-x","article-title":"Infections caused by Fusobacterium in children: a 14-year single-center experience.","volume":"43","author":"Shamriz","year":"2015","journal-title":"Infection"},{"key":"R15-20230928","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/nmi2.39","article-title":"Fusobacterium necrophorum, an emerging pathogen of otogenic and paranasal infections?","volume":"2","author":"Creemers-Schild","year":"2014","journal-title":"New Microbes New Infect"},{"key":"R16-20230928","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s10096-013-1848-2","article-title":"Fusobacterium invasive infections in children: a retrospective study in two French tertiary care centres.","volume":"32","author":"Bailhache","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R17-20230928","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/INF.0b013e318169035e","article-title":"Fusobacterium necrophorum middle ear infections in children and related complications: report of 25 cases and literature review.","volume":"27","author":"Le Monnier","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R18-20230928","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3201\/eid2002.131220","article-title":"Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children.","volume":"20","author":"Biesbroek","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"R19-20230928","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0163-4453(94)95600-6","article-title":"Fusobacterial infections in children.","volume":"28","author":"Brook","year":"1994","journal-title":"J Infect"},{"key":"R21-20230928","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/clinids\/18.4.633","article-title":"Septic pulmonary emboli complicating mastoiditis: Lemierre\u2019s syndrome revisited.","volume":"18","author":"Hughes","year":"1994","journal-title":"Clin Infect Dis"},{"key":"R22-20230928","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s11908-000-0030-z","article-title":"Lemierre\u2019s Syndrome.","volume":"2","author":"Armstrong","year":"2000","journal-title":"Curr Infect Dis Rep"},{"key":"R23-20230928","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2165\/00003495-199754050-00003","article-title":"Metronidazole. A therapeutic review and update.","volume":"54","author":"Freeman","year":"1997","journal-title":"Drugs"},{"key":"R24-20230928","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.anaerobe.2005.01.007","article-title":"Fusobacterium necrophorum infections in animals: pathogenesis and pathogenic mechanisms.","volume":"11","author":"Nagaraja","year":"2005","journal-title":"Anaerobe"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201901000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T02:19:22Z","timestamp":1695867562000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201901000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002021","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}